FDA Inspection 1251897 — ALS Czech Republic, S.R.O.

ALS Czech Republic, S.R.O. — FEI 3014498434

The FDA completed an inspection of ALS Czech Republic, S.R.O. on Feb 29, 2024 in Prague 9. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 29, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Prague 9 (Czech Republic)

Additional details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.